Related Experiment Videos
Contrast-processing deficits in melanoma-associated retinopathy
Kenneth R Alexander1, Claire S Barnes, Gerald A Fishman
1Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois 60612, USA. kennalex@uic.edu
Investigative Ophthalmology & Visual Science
|December 24, 2003
Summary
Patients with melanoma-associated retinopathy (MAR) exhibit contrast sensitivity loss not specific to the magnocellular pathway. This visual dysfunction is linked to spatial frequency and may stem from retinal bipolar cell issues.
Area of Science:
- Ophthalmology
- Neuroscience
- Visual Science
Background:
- Melanoma-associated retinopathy (MAR) is an autoimmune condition affecting vision.
- Previous hypotheses suggested a selective loss in the magnocellular (MC) pathway with sparing of the parvocellular (PC) pathway in MAR.
Purpose of the Study:
- To test the hypothesis of selective MC pathway dysfunction in MAR.
- To investigate the functional integrity of both MC and PC pathways in patients with MAR.
Main Methods:
- Contrast sensitivity was measured in two MAR patients and ten controls across various spatial frequencies (0.25-8 cpd).
- Two paradigms, steady pedestal and pulsed pedestal, were used to assess MC and PC pathway function, respectively.
- Visual acuity was assessed using standard Snellen charts.
Main Results:
- MAR patients showed reduced contrast sensitivity compared to controls.
- Sensitivity loss patterns varied between MC and PC pathway assessments and were spatial frequency-dependent.
- Normal visual acuity was maintained in MAR patients, even at high spatial frequencies.
Conclusions:
- Contrast sensitivity deficits in MAR are not solely MC-pathway specific but depend on spatial frequency.
- Findings suggest dysfunction at the retinal bipolar cell level as the underlying cause of MAR.
- The study refutes the selective MC pathway loss hypothesis for MAR.